1. Home
  2. KALA vs ICLK Comparison

KALA vs ICLK Comparison

Compare KALA & ICLK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KALA
  • ICLK
  • Stock Information
  • Founded
  • KALA 2009
  • ICLK 2009
  • Country
  • KALA United States
  • ICLK Hong Kong
  • Employees
  • KALA N/A
  • ICLK N/A
  • Industry
  • KALA Biotechnology: Pharmaceutical Preparations
  • ICLK Computer Software: Prepackaged Software
  • Sector
  • KALA Health Care
  • ICLK Technology
  • Exchange
  • KALA Nasdaq
  • ICLK Nasdaq
  • Market Cap
  • KALA 32.0M
  • ICLK 29.1M
  • IPO Year
  • KALA 2017
  • ICLK 2017
  • Fundamental
  • Price
  • KALA $6.77
  • ICLK $3.13
  • Analyst Decision
  • KALA Strong Buy
  • ICLK
  • Analyst Count
  • KALA 2
  • ICLK 0
  • Target Price
  • KALA $16.50
  • ICLK N/A
  • AVG Volume (30 Days)
  • KALA 36.4K
  • ICLK 24.9K
  • Earning Date
  • KALA 11-12-2024
  • ICLK 12-11-2024
  • Dividend Yield
  • KALA N/A
  • ICLK N/A
  • EPS Growth
  • KALA N/A
  • ICLK N/A
  • EPS
  • KALA N/A
  • ICLK N/A
  • Revenue
  • KALA N/A
  • ICLK $133,217,000.00
  • Revenue This Year
  • KALA N/A
  • ICLK $26.49
  • Revenue Next Year
  • KALA N/A
  • ICLK $12.11
  • P/E Ratio
  • KALA N/A
  • ICLK N/A
  • Revenue Growth
  • KALA N/A
  • ICLK N/A
  • 52 Week Low
  • KALA $4.21
  • ICLK $1.03
  • 52 Week High
  • KALA $10.97
  • ICLK $4.01
  • Technical
  • Relative Strength Index (RSI)
  • KALA 53.32
  • ICLK 47.28
  • Support Level
  • KALA $6.65
  • ICLK $3.05
  • Resistance Level
  • KALA $7.85
  • ICLK $3.20
  • Average True Range (ATR)
  • KALA 0.36
  • ICLK 0.13
  • MACD
  • KALA -0.02
  • ICLK -0.02
  • Stochastic Oscillator
  • KALA 7.43
  • ICLK 29.27

About KALA KALA BIO Inc.

Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.

About ICLK iClick Interactive Asia Group Limited

iClick Interactive Asia Group Ltd is an enterprise and marketing cloud Platform in China. It offers a consumer full lifecycle solution that addresses client's needs from traffic acquisition, customer relations management, and business decision optimization driven by data analytics in the retail era. It has two operating segments: Marketing Solutions, and Enterprise Solutions. Geographically, it derives the majority revenue from Mainland China and also has a presence in Hong Kong and other countries.

Share on Social Networks: